Nicholas Investment Partners, LP Amicus Therapeutics, Inc. Transaction History

Nicholas Investment Partners, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$8.38 - $13.44 $1.19 Million - $1.91 Million	-142,419 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$11.6 - $16.54 $21,935 - $31,277	-1,891 Reduced 1.31%	142,419 $1.72 Million
Q2 2018 Aug 14, 2018	BUY	$13.13 - $17.09 $235,184 - $306,116	17,912 Added 14.17%	144,310 $2.25 Million
Q1 2018 May 15, 2018	BUY	$13.76 - $17.12 $115,267 - $143,414	8,377 Added 7.1%	126,398 $1.9 Million
Q4 2017 Feb 14, 2018	SELL	$12.51 - $16.24 $204,751 - $265,800	-16,367 Reduced 12.18%	118,021 $1.7 Million
Q3 2017 Nov 13, 2017	BUY	$11.74 - $15.78 $1.58 Million - $2.12 Million	134,388	134,388 $2.03 Million

311

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.53B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Nicholas Investment Partners, LP with notifications on news.